LifeMD, Inc. (NASDAQ:LFMDP) Sees Large Drop in Short Interest

LifeMD, Inc. (NASDAQ:LFMDP) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 500 shares, a decline of 50.0% from the May 15th total of 1,000 shares. Based on an average trading volume of 6,200 shares, the days-to-cover ratio is currently 0.1 days.

LifeMD Stock Down 0.4%

NASDAQ:LFMDP traded down $0.09 during trading hours on Monday, reaching $23.75. 221 shares of the company’s stock were exchanged, compared to its average volume of 3,492. LifeMD has a 1-year low of $20.33 and a 1-year high of $27.44. The company has a 50-day moving average of $23.92 and a 200 day moving average of $23.24.

LifeMD Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Friday, April 4th were paid a dividend of $0.5547 per share. The ex-dividend date was Friday, April 4th. This represents a $2.22 annualized dividend and a dividend yield of 9.34%.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.